Sage Therapeutics (SAGE) PT Lowered to $42 at RBC Capital

February 17, 2022 6:48 AM EST Send to a Friend

RBC Capital analyst Brian Abrahams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sage Therapeutics (SAGE) PT Lowered to $42 at RBC Capital

Member Login

Free News Feed